3SBio Inc (1530 HK)

1H21 Earnings Call

Speakers

• Zhenping Zhu (President of Drug Development, Chief Scientific Officer, 3SBio Inc.)
• Fei Wang (Chief Financial Officer, 3SBio Inc.)
• Jing Lou (Chairman, Chief Executive Officer, 3SBio Inc.)

Recent Operational Update

2020 Annual Results Announcement Investor and Analyst Presentation

Speakers

• Jing Lou (Chairman & Chief Executive Officer, 3SBio Inc.)
• Zhenping Zhu (President of Drug Development, Chief Scientific Officer, 3SBio Inc.)
• Fei Wang (Chief Financial Officer, 3SBio Inc.)
• Lu Xia (Director of Investor Relations, 3SBio Inc.)
• Ziyi Chen (China Healthcare Analyst, Goldman Sachs (Asia) LLC)

3SBio (1530 HK) - 1H 2020 Results Briefing (Mandarin)

Speakers

• Dr. Jing LOU (Chairman & Chief Executive Officer, 3SBio Inc.)
• Fei WANG (Chief Financial Officer, 3SBio Inc.)
• Lu XIA (Director of Investor Relations, 3SBio Inc.)

Analysts

• Li Jian (Executive Director, China International Capital Corporation)

Duration

• Presentation: 19 minutes
• Q&A: 19 minutes